Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, December 25, 2024 in observance of Christmas and Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls With Polycystic Ovary Syndrome and Obesity

Endocrine Society's Annual Meeting

ENDO 2023

Chicago, IL, June 15-18, 2023

Poster presentation: Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity

Authors:  Lo JS, Bril F, Taylor A, Morelli N, Ware MA, Garcia-Reyes Y, McPhaul MJ, Cree MG

Specialty: Cardiovascular disease, Cardiology, Endocrinology

Related content

Conference Presentation
Measurement of Intact Insulin by Mass Spectrometry Identifies Nonalcoholic Fatty Liver Disease (NAFLD)
Test FAQ
Insulin Intact LC MS MS

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.